20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5834 | Myrcene | Others | |
Myrcene is a terpene that has been found in Cannabis and has antioxidative properties. | |||
T9192 | BIIB068 | BTK | |
BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases. | |||
T8316 | 1V209 | TLR7 agonist T7 | TLR |
1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist and has anti-tumor effects. | |||
T6649 | (S)-(+)-Rolipram | (S)-Rolipram,(+)-Rolipram,S- (+)-Rolipram | Apoptosis , PDE |
(S)-(+)-Rolipram ((+)-Rolipram) inhibits human monocyte cyclic AMP-specific PDE4 with IC50 of 0.75 μM, has anti-inflammatory and anti-depressant activity in the central nervous system, less potent than its R enantiomer. | |||
T0137 | Mirtazapine | 6-Azamianserin,Org3770 | Dopamine Receptor , 5-HT Receptor , Opioid Receptor , Adrenergic Receptor , Histamine Receptor |
Mirtazapine (6-Azamianserin) is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and h... | |||
T16501 | PF-3644022 | p38 MAPK , Serine Protease , MAPK | |
PF-3644022 is an effective, selective, and ATP-competitive MAPKAPK2 (MK2) inhibitor (IC50: 5.2 nM and a Ki of 3 nM). PF-3644022 potently inhibits TNFα production and has an anti-inflammatory effect. PF-3644022 also inhib... | |||
TP1626 | TNF-α (46-65), human | ||
Human TNF alpha (46-65) peptide. | |||
T36127 | TNF-α Antagonist | ||
TNF-α antagonist is an exocyclic peptide that mimics the critical TNF-α recognition loop on TNF receptor I complex and, thus, prevents ligand interaction with the receptor. By blocking the TNF receptor ligand contact sit... | |||
T9034 | MK2-IN-3 | MK2 Inhibitor III | MAPK |
MK2-IN-3 (MK2 Inhibitor III) is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis | |||
T71726 | TNFalpha-IN-S10 | ||
TNFalpha-IN-S10 is an inhibitor of TNF-α. | |||
T19584 | TNF-α (31-45), human | Others | |
TNF-α (31-45), human is a peptide of tumor necrosis factor-α. | |||
TP1537 | TNF-α (10-36), human | ||
TNF-α (10-36), human is a potent pro-inflammatory cytokine involved in the acute phase stress response. | |||
T20033 | Direct Violet 1 | NSC75778,NSC 75778,Airedale Violet ND,NSC-75778,Direct Violet N,CCRIS 2413 | SARS-CoV |
Direct Violet 1 (CCRIS 2413) is an agent of dye. | |||
T19584L | TNF-α (31-45), human acetate | TNF-α (31-45), human acetate(144796-71-4 free base) | Others |
TNF-α (31-45), human acetate is a peptide of tumor necrosis factor-α. | |||
T9537 | N'-Nitro-D-arginine | N'-Nitro-D-arginine,H-D-Arg(NO2)-OH,(R)-2-Amino-5-(3-nitroguanidino)pentanoic acid | Others |
N'-Nitro-D-arginine (N'-Nitro-D-arginine) is a Building Block. | |||
T7162 | R1487 Hydrochloride | R1487 (Hydrochloride) | p38 MAPK , Autophagy |
R1487 Hydrochloride (R1487 (Hydrochloride)) is an orally bioavailable and highly selective inhibitors of p38α. | |||
TP1636 | TNF-α (31-45), human TFA (144796-71-4 free base) | TNF-α (31-45), human TFA | |
TNF-α (31-45), human (TFA) is a peptide of tumor necrosis factor-α. | |||
TP1669 | TNF-α (46-65), human TFA (144796-72-5 free base) | TNF-α (46-65), human TFA | |
TNF-α (46-65), human (TFA) is a peptide of human TNF-α. | |||
TP1479 | TNF-α (10-36), human (TFA) (144796-70-3 free base) | TNF-α (10-36), human (TFA) | |
TNF-α (10-36), human (TFA) is a peptide of human TNF-α. | |||
T4637 | R-7050 | TNF-α Antagonist III | TNF |
R-7050 (TNF-α Antagonist III), a tumor necrosis factor receptor (TNFR) antagonist, exhibits heightened selectivity for TNFα. |